Keyphrases
Dose-response
100%
Retinol
100%
Cancer Recurrence
100%
Non-melanoma Skin Cancer
100%
Isotretinoin
100%
Hazard Ratio
85%
First Quartile
71%
Confidence Interval
57%
Squamous Cell Carcinoma (SqCC)
57%
Intent-to-treat Analysis
28%
Increasing Risk
28%
Basal Cell Carcinoma
28%
Original Intent
28%
High-risk Subjects
14%
Placebo
14%
Carcinoma Cells
14%
Adjusted Model
14%
Cox Proportional Hazards Model
14%
First Occurrence
14%
Response Format
14%
Testing Trends
14%
Squamous Carcinoma Cells
14%
Randomized Double-blind Study
14%
Pharmacology, Toxicology and Pharmaceutical Science
Retinol
100%
Non Melanoma Skin Cancer
100%
Isotretinoin
100%
Cancer Recurrence
100%
Squamous Cell Carcinoma
71%
Basal Cell Carcinoma
28%
Placebo
14%
Recurrent Disease
14%
Earth and Planetary Sciences